By Counterforce Health Team in Haegarda (C1-esterase inhibitor, SC) —

Work With Your Doctor to Get Haegarda Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization Guide

Answer Box: Getting Haegarda Covered by Blue Cross Blue Shield in New York

Blue Cross Blue Shield (BCBS) requires prior authorization for Haegarda with confirmed HAE diagnosis (low C4, C1-INH levels), attack history ≥2/month, and specialist prescriber. Fastest approval path: Submit complete PA packet via Availity provider portal with labs, medical necessity letter, and attack documentation. Start today: Schedule HAE specialist visit to gather diagnostic labs and treatment history. Appeals available through NY DFS external review if denied.

Table of Contents

  1. Set Your Goal: Understanding BCBS Requirements
  2. Visit Prep: What to Bring Your Doctor
  3. Evidence Kit: Building Your Case
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Support
  6. After-Visit Follow-Up
  7. Respectful Persistence and Appeals
  8. Cost Savings and Patient Assistance
  9. FAQ

Set Your Goal: Understanding BCBS Requirements

Your partnership with your HAE specialist is crucial for Haegarda approval. Blue Cross Blue Shield in New York requires prior authorization for all specialty biologics, and success depends on submitting a complete clinical package that meets their specific criteria.

Coverage Requirements at a Glance

Requirement What It Means Documentation Needed Source
Confirmed HAE Diagnosis Lab-proven Type I or II HAE Low C4, C1-INH levels (2 separate tests), normal C1q FDA labeling
Age ≥6 years FDA-approved indication Birth certificate or medical records Haegarda prescribing info
Specialist Prescriber Allergist/immunologist or HAE expert Provider credentials, NPI number BCBS PA guidelines
Attack History ≥2 attacks/month or significant impact Attack diary, ER records, hospitalizations Clinical documentation
Prior Therapy Trials Failed/contraindicated alternatives Treatment records, side effect notes Medical records

Your doctor will be your advocate throughout this process. Their clinical expertise and documentation skills directly impact approval odds.

Visit Prep: What to Bring Your Doctor

Come prepared to help your specialist build the strongest possible case. Organized documentation saves time and improves accuracy.

Essential Information to Gather

Attack Timeline (Past 12 months)

  • Dates of each attack
  • Body parts affected (face, throat, abdomen, extremities)
  • Severity (1-10 scale)
  • Duration (hours/days)
  • Treatment received (ER visits, medications used)
  • Work/school days missed

Previous Treatments Tried

  • Oral prophylaxis (berotralstat/Orladeyo)
  • IV C1-INH (Cinryze)
  • Androgens (danazol, stanozolol)
  • Antifibrinolytics (tranexamic acid)
  • Reasons for discontinuation (side effects, inadequate control, access issues)

Current Symptoms and Functional Impact

  • How HAE affects daily activities
  • Quality of life concerns
  • Anxiety about unpredictable attacks
  • Impact on work, relationships, travel
Tip: Keep a smartphone photo diary of swelling episodes. Visual documentation can be powerful supporting evidence for your case.

Evidence Kit: Building Your Case

Your specialist needs comprehensive documentation to justify Haegarda's medical necessity. Help them compile this evidence systematically.

Laboratory Documentation

Required HAE Diagnostic Tests (verify with the source linked below):

  • C4 complement level: Should be low on ≥2 occasions
  • C1-INH antigenic level: Low in Type I HAE
  • C1-INH functional assay: Low in both Type I and II HAE
  • C1q level: Normal (distinguishes from acquired angioedema)

Source: HAE diagnostic guidelines

Treatment History Summary

Create a chronological list of:

  1. First-line therapies attempted with dates, doses, duration
  2. Reasons for discontinuation (specific side effects, breakthrough attacks)
  3. Current attack frequency despite treatment
  4. Emergency interventions required (intubations, ICU stays)

Supporting Literature

Your doctor should reference:

  • FDA-approved Haegarda labeling for on-label prophylactic use
  • Current HAE management guidelines showing Haegarda as first-line therapy
  • Peer-reviewed studies demonstrating efficacy in attack prevention

Medical Necessity Letter Structure

Partner with your specialist to ensure their letter addresses BCBS's key decision points. Here's what successful letters include:

Template Framework

1. Patient Summary

  • Name, DOB, policy ID
  • HAE type and diagnosis date
  • Current attack frequency and severity

2. Clinical Rationale

  • Why Haegarda is medically necessary for this specific patient
  • Contraindications or failures with preferred alternatives
  • Risk of continued attacks without prophylaxis

3. Supporting Evidence

  • Reference to FDA approval for HAE prophylaxis
  • Guidelines supporting subcutaneous C1-INH as first-line therapy
  • Patient-specific factors favoring Haegarda over alternatives

4. Treatment Plan

  • Proposed dosing (typically 60 IU/kg twice weekly)
  • Monitoring plan
  • Expected outcomes

CSL Behring provides an official medical necessity template that your doctor can customize.

Peer-to-Peer Support

If BCBS requests a peer-to-peer review, your specialist will discuss your case directly with their medical director. You can help prepare them for success.

How to Support Your Doctor

Provide Availability Windows

  • Offer to coordinate scheduling between your doctor and BCBS
  • Ensure your specialist has advance notice of P2P requests

Prepare a Case Summary

  • One-page bullet points highlighting key clinical factors
  • Emphasis on failed alternatives and attack severity
  • Clear statement of why Haegarda is the appropriate choice

Follow-Up Coordination

  • Ask your doctor to document the P2P discussion outcome
  • Request next steps if additional information is needed
From our advocates: "We've seen cases where patients helped their doctors prepare talking points for peer-to-peer calls, focusing on specific failed therapies and attack patterns. This preparation often leads to same-day approvals when the clinical story is clear and well-documented."

After-Visit Follow-Up

Maintain momentum after your appointment by staying organized and responsive.

What to Save

  • Copy of prior authorization submission
  • Medical necessity letter
  • All supporting documentation
  • BCBS reference numbers and submission dates

Portal Communication

  • Use your patient portal to message questions
  • Respond promptly to requests for additional information
  • Keep your contact information current for PA updates

Timeline Tracking

  • Standard PA decisions: 5-15 business days
  • Expedited reviews: 24-72 hours for urgent cases
  • Appeal deadlines: 180 days for internal appeals, 4 months for external review in New York

Respectful Persistence and Appeals

If your initial PA is denied, work with your doctor to pursue appeals systematically.

Internal Appeals Process

Timeline: Submit within 180 days of denial Documentation: Include denial letter, additional clinical evidence, updated medical necessity letter Submission: Via BCBS provider portal or designated appeals fax

New York External Review

If internal appeals fail, New York offers robust external review rights through the Department of Financial Services.

Key Features:

  • Independent medical review by HAE specialists
  • Binding decisions on health plans
  • Expedited review available for urgent cases
  • Maximum $25 fee (waived for financial hardship)

Timeline: 4 months to file after final internal denial, 30-day decision (72 hours expedited)

When to Escalate Politely

  • No response after 15 business days
  • Requests for information already provided
  • Denial without clear clinical rationale

Maintain professional communication while advocating firmly for necessary care.

Cost Savings and Patient Assistance

Even with insurance approval, Haegarda can be expensive. Multiple assistance programs can help reduce your costs.

CSL Behring Support Programs

Haegarda Connect: 1-844-HAEGARDA (1-844-423-4273)

  • Field reimbursement managers for PA assistance
  • QuickStart program for eligible patients
  • Copay assistance programs

Additional Resources

  • Patient assistance foundations for HAE-specific grants
  • State pharmaceutical assistance programs in New York
  • Flexible spending accounts for out-of-pocket costs

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals for specialty medications like Haegarda. Their platform can help identify the specific reasons for denial and draft point-by-point rebuttals aligned to your plan's own rules, potentially saving months of back-and-forth with insurers.

FAQ

How long does BCBS prior authorization take in New York? Standard reviews take 5-15 business days. Expedited reviews for urgent cases are completed within 24-72 hours per New York state requirements.

What if Haegarda is non-formulary on my plan? Request a formulary exception with medical necessity documentation. Your doctor can argue that covered alternatives have failed or are contraindicated.

Can I request an expedited appeal if denied? Yes, if delayed treatment would seriously jeopardize your health. Document frequent severe attacks or airway involvement to support expedited review.

Does step therapy apply if I've failed treatments outside New York? Prior treatment failures should count regardless of where they occurred. Ensure your doctor documents all previous therapies with specific reasons for discontinuation.

What happens during a peer-to-peer review? Your specialist discusses your case directly with a BCBS medical director. Success rates are high (80-85%) when clinical rationale is clear and well-documented.

How much does external review cost in New York? Maximum $25 per appeal, capped at $75 per plan year. Fees are waived for Medicaid enrollees and financial hardship cases.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider for medical decisions. Insurance policies and requirements may change; verify current information with your plan and state regulators.

For complex cases requiring specialized appeal support, Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals tailored to each payer's specific requirements.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.